Biomerica Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Biomerica Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Irvine
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- May
- Ticker symbol
- BMRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000073290
- EIN
- 95-2645573
Board of directors
-
Allen Barbieri · Director · Executive Vice ChairmanSince 2023
-
Catherine Coste · DirectorSince 2023
-
David Moatazedi · DirectorSince 2022
-
Eric Chin · DirectorSince 2025
-
Jane Emerson · DirectorSince 2023
-
John P. Kenny · DirectorSince 2023
-
M. Huff Gary · DirectorSince 2025
-
Zackary S. Irani · Director · Chief Executive OfficerSince 2023
Chief executives
Zackary S. Irani
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of December 12, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
71.4%
-
75.3%
-
76.8%
-
84.8%
Board connections
3 of this board's directors also sit on 5 other boards.
- via Catherine Coste
- via David Moatazedi
- via John P. Kenny
- via John P. Kenny
- via John P. Kenny
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $158,000
- 5 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 26, 2026 | Allen Barbieri Director, Officer (Executive Vice Chairman) | Open-market purchase | +20,000 | $1.60 | $32,000 |
| Aug 26, 2026 | Zackary S. Irani Director, Officer (Chief Executive Officer) | Open-market purchase | +31,250 | $1.60 | $50,000 |
| Aug 26, 2026 | Eric Chin Director | Open-market purchase | +6,250 | $1.60 | $10,000 |
| Aug 26, 2026 | David Moatazedi Director | Open-market purchase | +10,000 | $1.60 | $16,000 |
| Aug 20, 2026 | M. Huff Gary Director | Open-market purchase | +31,250 | $1.60 | $50,000 |
| Dec 12, 2025 | Lu Gary Officer (Chief Financial Officer) | Grant or award | +40,000 | — | — |
| Dec 12, 2025 | Zackary S. Irani Director, Officer (Chief Executive Officer) | Grant or award | +52,500 | — | — |
| Dec 12, 2025 | Allen Barbieri Director, Officer (Executive Vice-Chairman) | Grant or award | +30,000 | — | — |
| Dec 12, 2025 | M. Huff Gary Director | Grant or award | +20,000 | — | — |
| Dec 12, 2025 | David Moatazedi Director | Grant or award | +20,000 | — | — |
| Dec 12, 2025 | Eric Chin Director | Grant or award | +22,500 | — | — |
| Dec 13, 2024 | Catherine Coste Director | Grant or award | +85,000 | $0.31 | $26,350 |
| Dec 13, 2024 | David Moatazedi Director | Grant or award | +85,000 | $0.31 | $26,350 |
| Dec 13, 2024 | Jane Emerson Director | Grant or award | +85,000 | $0.31 | $26,350 |
| Dec 13, 2024 | Zackary S. Irani Director, Officer (Chief Executive Officer) | Grant or award | +250,000 | $0.31 | $77,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.